Impact of Increased SGLT2 Inhibitor Uptake in CKD Management in Denmark: Modeling National Patient Benefits and Cost Savings
- DOI
- 10.1016/j.xkme.2026.101363
- Published
- 2026-06
- Container
- Kidney Medicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.xkme.2026.101363,
title = {Impact of Increased SGLT2 Inhibitor Uptake in CKD Management in Denmark: Modeling National Patient Benefits and Cost Savings},
author = {Renée Hangaard Olesen and Nicholas Carlson and Jens Søndergaard and Ellen Linnea Freese Ballegaard and Rikke Borg and Lars Holger Ehlers},
year = {2026},
journal = {Kidney Medicine},
doi = {10.1016/j.xkme.2026.101363},
url = {https://doi.org/10.1016/j.xkme.2026.101363}
}RIS
TY - JOUR TI - Impact of Increased SGLT2 Inhibitor Uptake in CKD Management in Denmark: Modeling National Patient Benefits and Cost Savings AU - Renée Hangaard Olesen AU - Nicholas Carlson AU - Jens Søndergaard AU - Ellen Linnea Freese Ballegaard AU - Rikke Borg AU - Lars Holger Ehlers PY - 2026 JO - Kidney Medicine DO - 10.1016/j.xkme.2026.101363 UR - https://doi.org/10.1016/j.xkme.2026.101363 ER -
APA
Olesen, R. H., Carlson, N., Søndergaard, J., Ballegaard, E. L. F., Borg, R., & Ehlers, L. H. (2026). Impact of Increased SGLT2 Inhibitor Uptake in CKD Management in Denmark: Modeling National Patient Benefits and Cost Savings. Kidney Medicine. https://doi.org/10.1016/j.xkme.2026.101363
Source records
- crossref · retrieved 2026-09-26T05:32:22.340Z